Market Introduction
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.
Market Overview and Dynamics
The North America cell therapy market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 7.4% from 2020 to 2027. Factors driving the market growth include growing collaborative efforts to promote cell therapy, and developments in cell therapy against COVID–19. However, stringent regulations is likely to restraint the market growth during the forecast period.
Key Market Segments
In terms of therapy type, in 2019, the allogeneic, and autologous. The allogeneic segment held the largest share of the market in 2019. The growth of segment is expected due to increasing focus on the development of regenerative therapies by increasingly emphasizing innovations and manufacturing. In addition, the availability of substantial number of approved products for clinical use is likely to continue the growth of segment during the forecast period. However, the autologous segment is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
World Health Organization, Food and Drug Administration, and American Society of Gene & Cell Therapy, and Stem Cell Network are some of the major primary and secondary sources for the North America cell therapy market included in the report.
Reasons to buy the report
North America Cell Therapy Market Segmentation
By Therapy Type
By Product
By Technology
By Application
By End User
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 291.39 Million |
| Market Size by 2027 | US$ 1,406.47 Million |
| CAGR (2020 - 2027) | 7.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Therapy Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Cell Therapy Market is valued at US$ 291.39 Million in 2019, it is projected to reach US$ 1,406.47 Million by 2027.
As per our report North America Cell Therapy Market, the market size is valued at US$ 291.39 Million in 2019, projecting it to reach US$ 1,406.47 Million by 2027. This translates to a CAGR of approximately 7.4% during the forecast period.
The North America Cell Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cell Therapy Market report:
The North America Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cell Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Cell Therapy Market
